Scilex Holding Company Increase (Decrease) in Other Current Liabilities
Scilex Holding Company (SCLX) reported Increase (Decrease) in Other Current Liabilities of -$3.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-14
- Scilex Holding Company increase (decrease) in other current liabilities for the quarter ending 2024-09-30 was -$191.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for the quarter ending 2024-06-30 was -$205.00K, a 123.30% decline year-over-year.
- Scilex Holding Company increase (decrease) in other current liabilities for the quarter ending 2024-03-31 was -$197.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for the quarter ending 2023-12-31 was -$192.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for fiscal 2023 was -$711.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for fiscal 2022 was -$392.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for fiscal 2021 was -$80.00K.
- Scilex Holding Company increase (decrease) in other current liabilities for fiscal 2020 was -$604.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.66M 10-Q · filed 2026-08-14 | ||||
| 2024-09-30 | -$191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | -$396.00K derived: sum of 2 quarters · filed 2025-01-17 | -$593.00K 10-Q · filed 2025-01-17 | -$785.00K derived: sum of 4 quarters · filed 2025-01-17 | |
| 2024-06-30 | -$205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$402.00K 10-Q · filed 2024-08-13 | -$594.00K derived: sum of 3 quarters · filed 2024-08-13 | -$1.82M derived: sum of 4 quarters · filed 2025-01-17 | |
| 2024-03-31 | -$197.00K 10-Q · filed 2024-05-13 | -$389.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.61M derived: sum of 3 quarters · filed 2025-01-17 | -$733.00K derived: sum of 4 quarters · filed 2025-01-17 | |
| 2023-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$1.42M derived: sum of 2 quarters · filed 2025-01-17 | -$536.00K derived: sum of 3 quarters · filed 2025-01-17 | -$711.00K 10-K · filed 2024-03-12 | |
| 2023-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | -$344.00K derived: sum of 2 quarters · filed 2025-01-17 | -$519.00K 10-Q · filed 2025-01-17 | -$656.00K derived: sum of 4 quarters · filed 2025-01-17 | |
| 2023-06-30 | $880.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $705.00K 10-Q · filed 2024-08-13 | -$338.00K 10-Q · filed 2023-08-11 | $568.00K derived: sum of 3 quarters · filed 2024-08-13 | $451.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$175.00K 10-Q · filed 2024-05-13 | -$312.00K derived: sum of 2 quarters · filed 2024-05-13 | -$429.00K derived: sum of 3 quarters · filed 2024-05-13 | -$555.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$254.00K derived: sum of 2 quarters · filed 2024-03-12 | -$380.00K derived: sum of 3 quarters · filed 2024-03-12 | -$392.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | -$117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$243.00K derived: sum of 2 quarters · filed 2023-11-14 | -$255.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$138.00K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$12.00K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | -$80.00K 10-K · filed 2024-03-12 | ||||
| 2020-12-31 | -$604.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |